Every Skin Treatment Category Is Forecasting Double-Digit Growth in 2026

The Professional Beauty Solutions Skin Summit 2026 put a hard figure on something the channel has been feeling all year, which is that patient demand for device-based skin treatments isn't slowing, and every major category is forecast to grow at double-digit rates from here.

The growth rates the Summit presented sit across four treatment categories that account for the bulk of clinical and professional skin work happening in Australia right now. Skin rejuvenation is forecast at 15% CAGR, skin tightening at 16%, vascular and pigmentation at 14%, and emerging modalities (the bucket holding newer technologies including cold fibre laser) at 18%. Take a beat with that. Every category, double digits, all of them sustained.

The honest read is that the market has stopped treating non-invasive treatments as a category and started treating them as the default. Anti-ageing used to live in cosmetic medicine, with consumers eventually working their way up to injectables when topical skincare hit its ceiling. The 15% growth rate on rejuvenation tells you that pathway has changed. The lift is being driven by patient demand for results without downtime, without recovery, and without a needle, and that demand is showing up in the appointment book of every clinic that has built the right device mix.

Images captured at The Skin Summit - Professional Aesthetic Solutions

Skin tightening at 16% is one of the most interesting numbers on the slide, and not because the figure itself is surprising.

Tightening has been the fastest-growing sub-segment in this space for several years running, and the forecast is telling you that's not slowing down. It sits at the intersection of two things clients are willing to pay for at scale (visible structural change, and a modality that works across face, body, and age brackets), and the device manufacturers know exactly what they have.

Expect more launches, more education investment, and more competitive pricing across this category through 2026 and into 2027.

The 14% growth on vascular and pigmentation is where the channel shift is most visible, and it's the number worth paying the closest attention to. These treatments have historically lived with dermatologists and cosmetic physicians, and skin clinics and salons have referred out anything requiring a vascular laser or a serious pigment-targeting device. That's changing, and the growth is being driven by chain operators expanding into modalities that used to require a specialist.

The implication for the channel is bigger than the number suggests, because once you have national chains diving further into vascular and pigmentation work, the conversation about training pathways, scope of practice, and what defines a clinic operator versus a medical practice gets very real, very quickly.

Emerging modalities at 18% is the headline number, and the slide called out cold fibre laser by name. Cold fibre is one of several newer technologies sitting outside the traditional tightening and rejuvenation categories, and an 18% forecast tells you the early adopters in this space are going to have a real window of differentiation before the modality becomes mainstream. The harder question for clinic owners isn't whether to look at emerging tech, it's how to evaluate which platforms are going to have staying power and which are going to flatten out once the novelty wears off.

Pulled together, the numbers tell you a few things very clearly. Skin treatment demand is real, sustained, and climbing across every category that matters. The consumer is fluent enough now to ask for specific outcomes by name, and the operators taking share are the ones building treatment menus around verified clinical results rather than chasing trend cycles.

For brand founders and BDMs working into the professional channel, the read is direct. Clinics are buying. Clients are returning. The categories with the strongest growth profile (tightening and emerging modalities) are also the categories where the right product or device alignment can move a clinic's revenue line meaningfully through the next twelve to eighteen months.

If you're not already having conversations with your stockists about how their treatment menu is shifting, that's a conversation worth booking before the rest of the channel does.